Target Mitochondrial Fitness, Chronobiology and Metabolism (PI19/00507)

Exercise could be an element that affects the biochemical, metabolic and microbiome parameters of organisms. Thus, to identify and validate the effects of aerobic and anaerobic exercises at different times of the day (morning or afternoon) on mitochondrial fitness and whether this changes could have a relation with metabolism and cardiovascular parameters and microbiome is of great interest for its applicability in biomedicine.

As specific objectives of this project will study:

  1. - To study the direct effect of aerobic and anaerobic exercise at different time points in the day on mitochondria fitness (short study: basal, at the end of the exercise and 2 h after exercise).
  2. - To study mitochondria fitness under morning or afternoon aerobic and anaerobic exercise (prospective study: basal, 4, 8 and 12 weeks of the study).
  3. - To identify and validate modulators and target proteins of mitochondria fitness affected by exercise (miRNA omic and proteomic analysis of mitochondria from the different groups of the study at basal and 12 weeks of the study).
  4. - To study the relationship of the mitochondrial response (Objectives 1 and 2) to the different combination of exercises and chronobiology with anthropometric-clinical, carbohydrate and lipid metabolic and cardiovascular changes.
  5. - To check the effect of morning or afternoon aerobic and anaerobic exercise on gut microbiota and its relation to mitochondria fitness, clinical and metabolic parameters (basal, 4, 8 and 12 weeks of the study).

Study Overview

Status

Active, not recruiting

Conditions

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Málaga, Spain, 29010
        • Hospital Universitario Virgen de la Victoria

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 53 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 20-
  • IMC <30 kg/m2
  • Informed consent

Exclusion Criteria:

  • Smoker
  • Previous physical exercise of more than 20 minutes / 2 times a week

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exercise arm
Subjects perfom aerobic or anaerobic exercise in the morning or in the afternoon
Aerobic or anaerobic exercise in the morning or in the afternoon

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in weight
Time Frame: From baseline to week 12
Weight in kg
From baseline to week 12
BMI (body mass index) changes
Time Frame: From baseline to week 12
Measured by body composition analysis
From baseline to week 12
Change in waist circumference
Time Frame: From baseline to week 12
Circumference in cm
From baseline to week 12
Change in hip circumference
Time Frame: From baseline to week 12
Circumference in cm
From baseline to week 12
Changes in diastolic and systolic blood pressure
Time Frame: From baseline to week 12
To analyze the effect of exercise on blood pressure
From baseline to week 12
Changes in body composition
Time Frame: From baseline to week 12
To analyze the effect of exercise on anthropometric parameters measured by bioelectrical impedance analysis
From baseline to week 12
Change in glucose concentration
Time Frame: From baseline to week 12
Glucose in mg/dl
From baseline to week 12
Change in insulin concentration
Time Frame: From baseline to week 12
Insulin in mg/dl
From baseline to week 12
Change in glycated haemoglobin concentration
Time Frame: From baseline to week 12
Glycated haemoglobin in mg/dl
From baseline to week 12
Change in Triglycerides concentration
Time Frame: From baseline to week 12
Triglycerides in mg/dl
From baseline to week 12
Change in cholesterol concentration
Time Frame: From baseline to week 12
Serum cholesterol in mg/dl
From baseline to week 12
Change in HDL concentration
Time Frame: From baseline to week 12
Serum HDL in mg/dl
From baseline to week 12
Change in LDL concentration
Time Frame: From baseline to week 12
Serum LDL in mg/dl
From baseline to week 12
Change in transaminases concentration
Time Frame: From baseline to week 12
Serum transaminases in UI/l
From baseline to week 12
Change in creatinine concentration
Time Frame: From baseline to week 12
Creatinine in mg/dl
From baseline to week 12
Change in uric acid concentration
Time Frame: From baseline to week 12
Uric acid in mg/dl
From baseline to week 12
Change in alkaline phosphatase concentration
Time Frame: From baseline to week 12
Serum alkaline phosphatase in UI/l
From baseline to week 12
Change in bilirubin concentration
Time Frame: From baseline to week 12
Serum bilirubin in mg/dl
From baseline to week 12
Change in lactate concentration
Time Frame: From baseline to week 12
Serum lactate in mmol/L
From baseline to week 12
Change in cortisol concentration
Time Frame: From baseline to week 12
Serum cortisol in nmol/L
From baseline to week 12
Change in total and free testosterone concentration
Time Frame: From baseline to week 12
Serum total and free testosterone in nmol/L
From baseline to week 12
Change in melatonine concentration
Time Frame: From baseline to week 12
Serum melatonine in pg/ml
From baseline to week 12
Characterize exercise participant behavior
Time Frame: From baseline to week 12
International Physical Activity Questionnaire (IPAQ). The IPAQ consists of 7 questions about the frequency, duration and intensity of activity (moderate and intense) carried out in the last seven days, as well as walking and sitting time in a work day. It evaluates three characteristics of physics (PA): intensity (mild, moderate or vigorous), frequency (days per week) and duration (time per day). Weekly activity is recorded in Mets (Metabolic Equivalent of Task or Metabolic Index Units) per minute and week.
From baseline to week 12
Mediterranean diet adherence questionnaire
Time Frame: From baseline to week 12
To evaluate adherence to a Mediterranean diet pattern. It consists of 14 items in which different components of the Mediterranean diet are evaluated (number of pieces of fruit consumed per day, number of portions of legumes consumed per week...). Each item is scored as 0 or 1. A total score of <9 indicates poor adherence, while a score of ≥9 indicates good adherence.
From baseline to week 12
Change in faecal microbiota
Time Frame: From baseline to week 12
To evaluate faecal microbiota composition in the studied subjects and the effect of aerobic and anaerobic exercise in the morning or afternoon on faecal microbiota composition. 16S rRNA amplicons of fecal community DNA
From baseline to week 12
Change in fitness mitochondrial
Time Frame: From baseline to week 12
To evaluate the effect of aerobic and anaerobic exercise in the morning or afternoon on mitochondrial fitness, evaluated by mitochondrial gene expression and protein abundance, mitochondrial metabolites, mitochondrial markers trough flow citometry.
From baseline to week 12

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mora Murri Pierri, PhD, Hospital Universitario Virgen de la Victoria

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 18, 2021

Primary Completion (Actual)

July 29, 2022

Study Completion (Anticipated)

December 31, 2023

Study Registration Dates

First Submitted

October 26, 2022

First Submitted That Met QC Criteria

October 26, 2022

First Posted (Actual)

October 31, 2022

Study Record Updates

Last Update Posted (Actual)

November 2, 2022

Last Update Submitted That Met QC Criteria

October 31, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • PI19/00507

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Subjects

Clinical Trials on Aerobic or anaerobic exercise

3
Subscribe